|
98
|
267
|
5oimA |
Inha (t2a mutant) complexed with ethyl 2-methyl-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate |
|
94
|
268
|
5oitB |
Inha (t2a mutant) complexed with 5-((5-amino-3-methyl-1h-pyrazol-1-yl)methyl)-n-(1-(2-chloro-6-fluorobenzyl)-1h-pyrazol-3-yl)-1,3,4-thiadiazol-2-amine |
|
99
|
267
|
5oirA |
Inha (t2a mutant) complexed with 2,6-dimethyl-3-(1-(pyrimidin-2-yl)piperidin-4-yl)pyridin-4(1h)-one |
|
95
|
267
|
5oilA |
Inha (t2a mutant) complexed with 1-cyclohexyl-3-(pyridin-3-ylmethyl)urea |
|
94
|
268
|
5oioA |
Inha (t2a mutant) complexed with 5-((3,5-dimethyl-1h-pyrazol-1-yl)methyl)-n-ethyl-1,3,4-thiadiazol-2-amine |
|
95
|
268
|
5oisB |
Inha (t2a mutant) complexed with 4-((5-amino-3-methyl-1h-pyrazol-1-yl)methyl)-n-(2-chloro-4-fluorobenzyl)benzamide |
|
95
|
268
|
5oipA |
Inha (t2a mutant) complexed with 1-(pyridin-3-ylmethyl)-3-(1-(pyrimidin-2-yl)piperidin-4-yl)urea |
|
95
|
267
|
5oifA |
Inha (t2a mutant) complexed with 1-benzyl-3-methyl-1h-pyrazol-5-amine |
|
89
|
267
|
5oiqA |
Inha (t2a mutant) complexed with 2,6-dimethyl-3-phenylpyridin-4(1h)-one |
|
98
|
267
|
5oicA |
Inha (t2a mutant) complexed with (4-((1h-pyrazol-1-yl)methyl)phenyl)methanol |
|
95
|
268
|
5oinA |
Inha (t2a mutant) complexed with n-(1-(pyrimidin-2-yl)piperidin-4-yl)acetamide |
|
149
|
405
|
5jaqA |
Yersinia pestis fabv variant t276c |
|
95
|
257
|
5i9mA |
Crystal structure of b. pseudomallei fabi in complex with nad and pt408 |
|
92
|
257
|
5i8zA |
Crystal structure of b. pseudomallei fabi in complex with nad and pt12 |
|
101
|
311
|
5gvhA |
Structure of fabk from thermotoga maritima |
|
97
|
268
|
5g0wA |
Inha in complex with a dna encoded library hit |
|
98
|
268
|
5g0uA |
Inha in complex with a dna encoded library hit |
|
92
|
268
|
5g0vA |
Inha in complex with a dna encoded library hit |
|
146
|
405
|
5g2oA |
Yersinia pestis fabv variant t276a |
|
92
|
268
|
5g0sA |
Inha in complex with a dna encoded library hit |
|
93
|
267
|
5g0tA |
Inha in complex with a dna encoded library hit |
|
105
|
311
|
5gvjA |
Structure of fabk (m276a) mutant from thermotoga maritima |
|
86
|
267
|
5cpfA |
Compensation of the effect of isoleucine to alanine mutation by designed inhibition in the inha enzyme |
|
93
|
268
|
5coqA |
The effect of valine to alanine mutation on inha enzyme crystallization pattern and substrate binding loop conformation and flexibility |
|
97
|
267
|
5cp8A |
The effect of isoleucine to alanine mutation on inha enzyme crystallization pattern and substrate binding loop conformation and flexibility |
|
93
|
268
|
5cpbA |
The effect of isoleucine to alanine mutation on inha enzyme crystallization pattern and inhibition by ligand pt70 (tcu) |
|
98
|
268
|
4uvgA |
Discovery of pyrimidine isoxazoles inha in complex with compound 15 |
|
93
|
268
|
4uvhA |
Discovery of pyrimidine isoxazoles inha in complex with compound 10 |
|
93
|
268
|
4uviA |
Discovery of pyrimidine isoxazoles inha in complex with compound 23 |
|
101
|
268
|
4uveA |
Discovery of pyrimidine isoxazoles inha in complex with compound 9 |
|
100
|
268
|
4uvdA |
Discovery of pyrimidine isoxazoles inha in complex with compound 6 |
|
99
|
268
|
4troA |
Structure of the enoyl-acp reductase of mycobacterium tuberculosis inha, inhibited with the active metabolite of isoniazid |
|
96
|
268
|
4trnA |
Structure of inha from mycobacterium tuberculosis complexed to nadh |
|
95
|
268
|
4tzkA |
Crystal structure of mycobacterium tuberculosis enoyl reductase (inha) complexed with 1-cyclohexyl-n-(3,5-dichlorophenyl)-5-oxopyrrolidine-3-carboxamide |
|
95
|
268
|
4tztA |
Crystal structure of mycobacterium tuberculosis enoyl reductase (inha) complexed with n-(3-chloro-2-methylphenyl)-1-cyclohexyl- 5-oxopyrrolidine-3-carboxamide |
|
99
|
268
|
4u0jA |
Crystal structure of mycobacterium tuberculosis enoyl reductase (inha) complexed with 1-cyclohexyl-5-oxo-n-phenylpyrrolidine-3-carboxamide, refined with new ligand restraints |
|
98
|
267
|
4u0kA |
Crystal structure of mycobacterium tuberculosis enoyl reductase complexed with n-(5-chloro-2-methylphenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide |
|
93
|
268
|
4trjA |
Crystal structure of mycobacterium tuberculosis enoyl reductase (inha) complexed with n-(3-bromophenyl)-1-cyclohexyl-5-oxopyrrolidine-3-carboxamide, refined with new ligand restraints |
|
90
|
267
|
4trmA |
Structure of the apo form of inha from mycobacterium tuberculosis |
|
92
|
268
|
4r9sA |
Mycobacterium tuberculosis inha bound to nitd-916 |
|
90
|
267
|
4r9rA |
Mycobacterium tuberculosis inha bound to nitd-564 |
|
102
|
295
|
4q9nA |
Crystal structure of chlamydia trachomatis enoyl-acp reductase (fabi) in complex with nadh and afn-1252 |
|
96
|
258
|
4rlhA |
Crystal structure of enoyl acp reductase from burkholderia pseudomallei in complex with afn-1252 |
|
100
|
268
|
4qxmA |
Crystal structure of the inha:gsk_sb713 complex |
|
95
|
267
|
4oxkA |
Multiple binding modes of inhibitor pt155 to the mycobacterium tuberculosis enoyl-acp reductase inha within a tetramer |
|
98
|
267
|
4oyrA |
Competition of the small inhibitor pt91 with large fatty acyl substrate of the mycobacterium tuberculosis enoyl-acp reductase inha by induced substrate-binding loop refolding |
|
97
|
268
|
4oxnA |
Substrate-like binding mode of inhibitor pt155 to the mycobacterium tuberculosis enoyl-acp reductase inha |
|
101
|
268
|
4oxyA |
Substrate-binding loop movement with inhibitor pt10 in the tetrameric mycobacterium tuberculosis enoyl-acp reductase inha |
|
107
|
303
|
4o1mA |
Toxoplasma gondii enoyl acyl carrier protein reductase |
|
100
|
267
|
4oimA |
Crystal structure of mycobacterium tuberculosis inha in complex with inhibitor pt119 in 2.4 m acetate |
